Xencor, Inc. (XNCR)
12.87
+0.42
(+3.37%)
USD |
NASDAQ |
Apr 17, 10:44
Xencor Research and Development Expense (Quarterly) : 64.82M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 2.151B |
| Merck & Co., Inc. | 2.499B |
| Rigel Pharmaceuticals, Inc. | 10.68M |
| MacroGenics, Inc. | 32.27M |
| Ultragenyx Pharmaceutical, Inc. | 194.22M |